METVIX crème tb 2 g

7680561340017 CH-56134 L01XD03 07.16.4.
METVIX crème tb 2 g
METVIX crème tb 2 g
METVIX crème tb 2 g
1 / 3
google

Details

Product number
5613401
CPT
-
Packaging group
2
Unit
g
Composition
methylis aminolaevulinas 160 mg ut methylis aminolaevulinatis hydrochloridum, glyceroli monostearas emulsifcans, alcohol cetylicus et stearylicus 40 mg, macrogoli stearas, E 218 2 mg, propylis parahydroxybenzoas 1 mg, dinatrii edetas, glycerolum, vaselinum album, cholesterolum, isopropylis myristas, arachidis oleum 30 mg, amygdalae oleum, alcohol oleicus, aqua, ad unguentum pro 1 g.

Articles (1)

Metvix, Crème
Crème
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/11/2022
Professional SmPC
Français
21/11/2022
Professional SmPC
Italien
21/11/2022

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
40.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
2.0 MG Substance HBESI
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
30.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 215.60
Specialties list
Yes
Generic
No
SL addition date: 01/01/2004

Authorization holder

Galderma SA

6300 Zug

Authorization information

Swissmedic authorization number
56134
Drug name
Metvix, Crème
Galenic form
CREM
ATC Code
L01XD03
Authorization status
Z
Dispensation category
B
First authorization
05/11/2003
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Aktinische Keratose und oberflächliches Basaliom

Packaging details

Description (FR)
METVIX crème tb 2 g
Description (DE)
METVIX Creme Tb 2 g
Market launch
05/11/2003
Narcotic (BTM)
No